Paroxysmal Atrial Fibrillation, Stroke
Conditions
Keywords
Cardiac monitoring, Biomarkers, Transthoracic echocardiography
Brief summary
This propsective study aims to compare the diagnostic yield of a Personal Heart Rhythm Monitor (PHRM) with an automated cardiac event recorder (ACER) to detect paroxysmal Atrial Fibrillation PAF). The investigators hypothesise that the PHRM, used intermittently for 3 months, will detect significantly more cases of PAF than the ACER, used continuously for one week. A case-control sub-study will identify individuals with confirmed PAF, and matched individuals with no evidence of PAF, to identify potential serum biomarkers for PAF. A further case-control study will assess markers of left atrial function in patients with PAF and their matched controls. Another case-control sub-study will determine the significance of frequent Atrial Premature Beats (APBs) in the development of AF over a one year period.
Detailed description
Patients with suspected AF will be initially referred to a community-based, nurse-led Arrhythmia clinic by their General Practitioners over a 15-month period. All patients will be issued with a one week ACER (the 'R. Test 4 Evolution'), seen as the 'best-practice' investigation for this population group. Participants will also be issued with a PHRM for three months. They will be instructed to take regular twice-daily, 30 second recordings with additional recordings in the event of relevant symptoms. They will return the ACER after one week and the PHRM after 3 months. A subgroup of participants (target recruitment number = 100) will undergo transthoracic echocardiography. A 40ml venous blood sample will also be taken. Another small subgroup (target recruitment = 20) will be asked to continue twice-daily recordings using the PHRM for a further nine months and will be issued with a repeat one week ACER at study completion.
Interventions
Automated Cardiac Event Recorder to be worn continuously for one week.
Personal Heart Rhythm Monitor to be used twice-daily for three months.
Sponsors
Study design
Eligibility
Inclusion criteria
* Suspected paroxysmal AF (either palpitations consistent with AF or an irregular pulse) * 12-lead resting ECG confirming sinus rhythm * Capacity to consent to study * English-speaking * Life expectancy at least one year
Exclusion criteria
* Previous diagnosis of AF * Recent history of syncope * Recent history of cardiac-sounding chest pain * A resting ECG suggestive of alternative arrhythmia * Inability to use the telephone * Thyrotoxicosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The diagnostic yield of a Personal Heart Rhythm Monitor (PHRM), used for 3 months, compared to an automated cardiac event recorder (ACER), used for 1 week, to detect all episodes of paroxysmal atrial fibrillation. | 18 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Stroke reduction in the local area | 30 months | A reduction in stroke burden in the local area will be calculated from estimated stroke risk in individuals identified with AF and from a local registry. |
| Referrals to secondary care for suspected AF/palpitations | 18 months | The number of referrals to secondary care for suspected PAF will be analysed. |
| Participant satisfaction with the devices used in the study. | 18 months | — |
| Adverse events (including stroke/TIA, myocardial infarction, significant bleeding events and death) at six and twelve month intervals. | 30 months | — |
| The sensitivity and specificity of serum biomarkers to detect cases of PAF. | 18 months | — |
| The sensitivity and specificity of markers of left atrial function to predict PAF. | 18 months | — |
| The development of AF in a cohort confirmed to have frequent atrial ectopic beats (APBs) over a one year period. | 18 months | — |
| The diagnostic yield of a Personal Heart Rhythm Monitor (PHRM), used for 3 months, compared to an automated cardiac event recorder (ACER), used for 1 week, to detect prolonged episodes of paroxysmal atrial fibrillation (defined as greater than 12 hours). | 18 months | — |
Countries
United Kingdom